Targeting thermogenesis and related pathways in anti-obesity drug discovery

Area of Science:

• Pharmacology and metabolic research focusing on obesity treatment.
• Exploration of thermogenesis as a therapeutic target for weight management.

Background:

• The global obesity epidemic presents a significant unmet therapeutic need.
• Current treatments like lifestyle modification and bariatric surgery have limitations.
• The history of obesity pharmacotherapy is marked by safety concerns and regulatory withdrawals.

Purpose of the Study:

• To review the pharmacological approach of increasing calorie expenditure (thermogenesis) for obesity.
• To discuss regulatory requirements and the scientific rationale for targeting thermogenesis.
• To examine potential strategies for increasing human thermogenesis.

Main Methods:

• Review of existing literature on obesity pharmacotherapy and thermogenesis.
• Analysis of the challenges in validating thermogenic drugs in human studies.
• Discussion of abnormal metabolic responses post-weight loss contributing to regain.

Main Results:

• Limited success and safety concerns plague current pharmacological obesity treatments.
• Increasing thermogenesis is a promising, albeit challenging, approach.
• Accumulating sufficient human data to validate thermogenic drug efficacy remains a key hurdle.

Conclusions:

• Targeting thermogenesis offers a potential avenue for novel obesity pharmacotherapy.
• Overcoming challenges in human data acquisition is crucial for drug development.
• Further research is needed to validate thermogenic strategies for long-term obesity management.